{
    "clinical_study": {
        "@rank": "18323", 
        "arm_group": {
            "arm_group_label": "rHSA/GCSF for injection", 
            "arm_group_type": "Experimental", 
            "description": "rHSA/GCSF Start from 300mcg"
        }, 
        "brief_summary": {
            "textblock": "Safety and efficacy studies of rHSA/GCSF fusion protein for injection in treatment of\n      neutropenia induced by chemotherapy of cancer patients."
        }, 
        "brief_title": "Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Underdose (Unintentional)", 
            "Cancer", 
            "Tumor"
        ], 
        "condition_browse": {
            "mesh_term": "Neutropenia"
        }, 
        "detailed_description": {
            "textblock": "A dosage climbing for the safety and efficacy studies for the neutropenia induced by\n      chemotherapy cancer patients Repeat-dose studies for the safety and efficacy studied for the\n      neutropenia."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - chemotherapy induced neutropenia\n\n        Exclusion Criteria:\n\n        - treated with other biological drugs or other neutropenia therapy drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "28", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01919710", 
            "org_study_id": "9314-rHSA/GCSF", 
            "secondary_id": "2011L01837"
        }, 
        "intervention": {
            "arm_group_label": "rHSA/GCSF for injection", 
            "description": "for treatment of neutropenia", 
            "intervention_name": "rHSA/GCSF", 
            "intervention_type": "Drug", 
            "other_name": "Long acting rhG-CSF fusion protein"
        }, 
        "intervention_browse": {
            "mesh_term": "Lenograstim"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Neutropenia", 
            "chemotherapy", 
            "rHSA/GCSF"
        ], 
        "lastchanged_date": "August 6, 2013", 
        "location": {
            "contact": {
                "email": "songyuqin622@sina.com", 
                "last_name": "Yuqin Song, MD", 
                "phone": "86-136-8339-8726"
            }, 
            "contact_backup": {
                "email": "frank.dingning@gmail.com", 
                "last_name": "Ning Ding, MD", 
                "phone": "86-182-1104-1605"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "zip": "100142"
                }, 
                "name": "Beijing Cancer Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Jun ZHU, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Yuqin SONG, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase 1 Study of rHSA/GCSF in Neutropenia After Chemotherapy of Cancer Patients", 
        "overall_contact": {
            "email": "zyu88@yahoo.com", 
            "last_name": "Zailin YU, Professor", 
            "phone": "86-137-0101-4142"
        }, 
        "overall_contact_backup": {
            "email": "yfu88@yahoo.com", 
            "last_name": "Yan FU, PhD", 
            "phone": "86-10-6276-0812"
        }, 
        "overall_official": {
            "affiliation": "Beijing Cancer Hospital", 
            "last_name": "Jun ZHU, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Number of participants with adverse events as a measure for safety and tolerability after single and multiple dose of rHSA/GCSF", 
            "measure": "Number of adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "14 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01919710"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "AUC after single and multiple dose of rHSA/GCSF", 
            "measure": "AUC", 
            "safety_issue": "No", 
            "time_frame": "14 days"
        }, 
        "source": "Tianjin SinoBiotech Ltd.", 
        "sponsors": {
            "collaborator": {
                "agency": "Beijing Cancer Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Tianjin SinoBiotech Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}